Edition:
United Kingdom

Indivior PLC (INDV.L)

INDV.L on London Stock Exchange

260.10GBp
21 Sep 2018
Change (% chg)

-5.50 (-2.07%)
Prev Close
265.60
Open
267.70
Day's High
268.50
Day's Low
257.40
Volume
3,168,703
Avg. Vol
3,105,830
52-wk High
504.60
52-wk Low
238.00

Summary

Name Age Since Current Position

Howard Pien

Executive Chairman of the Board

Shaun Thaxter

Chief Executive Officer, Executive Director

Mark Crossley

2017 Chief Financial Officer, Executive Director

Jon Fogle

Chief Human Resource Officer

Ingo Elfering

2017 Chief Information and Innovation Officer

Christian Heidbreder

Chief Scientific Officer

Debby Betz

Chief Corporate Affairs and Communications Officer

Javier Rodriguez

Chief Legal Officer

Richard Simkin

Chief Commercial and Strategy Officer

Frank Stier

Chief Manufacturing and Supply Officer

Ponni Subbiah

Chief Medical Officer

Kathryn Hudson

Company Secretary

Tatjana May

49 2017 Non-Executive Director

A. Thomas McLellan

2014 Non-Executive Director

Daniel Tasse

58 2016 Senior Independent Director

Yvonne Greenstreet

2014 Non-Executive Independent Director

Lorna Parker

Non-Executive Independent Director

Daniel Phelan

68 Non-Executive Independent Director

Christian Schade

57 Non-Executive Independent Director

Lizabeth Zlatkus

59 2016 Non-Executive Independent Director

Biographies

Name Description

Howard Pien

Mr. Howard Pien serves as Executive Chairman of the Board of Indivior Plc. He has Over 30 years of pharmaceutical and biotechnology industry experience, Vanda Pharmaceuticals, Inc.: Non-Executive Chairman (2010-2016), GlaxoSmithKline: various executive positions (1991-2003), Chiron, Corp: President and CEO (2003-2006) and later Chairman of the Board (2004-2006), Medarex Inc.: CEO and President(2007-2009), Abbott Laboratories and Merck & Co.: Product Manager, Business Unit Director, cardiovasculars, anti-infectives(1986-1991). Other current appointments: Juno Therapeutics Inc.: Chairman of the Board, Sapience Therapeutics: Chairman.

Shaun Thaxter

Mr. Shaun Thaxter serves as Chief Executive Officer, Executive Director of Indivior Plc. Over 25 years of pharmaceutical and prescription products industry experience, Appointed CEO of Indivior at time of Reckitt Benckiser Pharmaceuticals demerger, Institute of Directors (IoD): Chartered Director and Fellow, National Association of Corporate Directors (NACD): Board Leadership Fellow, Reckitt Benckiser Pharmaceuticals, Inc.: President, Reckitt Benckiser: Global Category Manager.

Mark Crossley

Mr. Mark Crossley serves as Chief Financial Officer, Executive Director of the Company. Indivior Chief Strategy Officer, Reckitt Benckiser Pharmaceuticals Inc.: Global Finance Director, Procter and Gamble: Associate Director Corporate Portfolio Finance, Procter and Gamble: Associate Director Female Beauty Strategy and Business Planning, National Association of Corporate Directors (NACD): Board Leadership Fellow.

Jon Fogle

Mr. Jon Fogle serves as Chief Human Resource Officer of the Company. Industry experience: 20+ years. Professional qualifications: Senior Certified Professional in Human Resources. Key previous roles: Reckitt Benckiser Pharmaceuticals Inc.: Global Human Resources Director, Reckitt Benckiser Pharmaceuticals Inc.: Human Resources Director for the US, Capmark Finance (formerly GMAC Commercial Mortgage): Senior Vice President of Human Resources, North America.

Ingo Elfering

Mr. Ingo Elfering serves as Chief Information and Innovation Officer of the Company. Industry experience: 25+ years. Key previous roles: GlaxoSmithKline: VP Business Transformation Core Business Service Group, GlaxoSmithKline: VP IT Roles (Strategy, Architecture, Global Services, eBusiness), Medical Data Service Founder/CEO.

Christian Heidbreder

Mr. Christian Heidbreder serves as Chief Scientific Officer of the Company. Industry experience: 25+ years. Professional experience: 26 years’ leadership in neurosciences across academia, government, industry;, 350+ publications, Academic roles: Affiliate Professor, Dept. Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine. Key previous roles: Reckitt Benckiser Pharmaceuticals Inc.: Global R&D Director, Altria: Client Services’ Health Sciences, GlaxoSmithKline: Center of Excellence for Drug Discovery in Psychiatry, SmithKline Beecham: Neuroscience Department.

Debby Betz

Mr. Debby Betz is Chief Corporate Affairs and Communications Officer of the Company. Industry experience: 25+ years. Key previous roles: Reckitt Benckiser Pharmaceuticals Inc.: Director of Marketing (North America) and Director of Commercial Development and Strategic Planning (North America), Purdue Pharma and Stuart Pharmaceuticals: Various sales and marketing leadership roles including District Sales Manager.

Javier Rodriguez

Mr. Javier Rodriguez is Chief Legal Officer of the Company. Professional qualifications: Admitted to practice law in New York, New Jersey and Virginia (Corporate Counsel), National Association of Corporate Directors Governance Fellow. Key previous roles: Reckitt Benckiser Pharmaceuticals Inc.: VP General Counsel, Reckitt Benckiser LLC: Senior Counsel (Healthcare), helping to acquire the global (ex-US) marketing rights to buprenorphine, Bayer AG and Berlex Laboratories, Inc.: Corporate Counsel.

Richard Simkin

Mr. Richard Simkin is Chief Commercial and Strategy Officer of the Company. Key previous roles: Reckitt Benckiser Pharmaceuticals Inc.: President, North America, Reckitt Benckiser: General Manager Portugal, Reckitt Benckiser: Marketing Director UK Healthcare, Reckitt Benckiser: Two Global Category roles and a number of General Management positions.

Frank Stier

Mr. Frank Stier is Chief Manufacturing and Supply Officer of the Company. Industry experience: 25+ years Key previous roles: Reckitt Benckiser Pharmaceuticals Inc.: Global Supply Director (heading logistics, customer service, demand planning and manufacturing) Reckitt Benckiser Pharmaceuticals Inc.: Supply Services Director then Global Supply Services Director Reckitt Benckiser: Supply Services Director, Central Europe Reckitt Benckiser: Industrial Customer Service Manager Colgate-Palmolive GmbH: Various roles.

Ponni Subbiah

Mr. Ponni Subbiah is Chief Medical Officer of the Company. Professional qualifications: Neurologist, Masters in Public Health, New York State Medical License. Key previous roles: PATH: Global Program Leader, Drug Development, Pfizer, Inc.: Vice President , Global Access, Emerging Markets, Pfizer, Inc.: Vice President, Medical Affairs.

Kathryn Hudson

Ms. Kathryn Hudson serves as Company Secretary of the Company. Over 15 years of experience as a Chartered Secretary, Fellow of the Institute of Chartered Secretaries and Administrators, Kingfisher plc: Company Secretary(2012-2015), Senior Company Secretarial positions at Burberry Group plc and ICAP plc.

Tatjana May

Ms. Tatjana May serves as Non-Executive Director of the Company. Over 20 years of legal experience, Substantial knowledge and understanding of the pharmaceutical sector, Shire plc: General Counsel and Company Secretary, Executive Committee Member (2001-2015), AstraZeneca plc: various positions including Assistant General Counsel (1995-2001), Slaughter and May: Lawyer (1988-1994). Other current appointments: EIP Pharma, LLC: Board of Managers, The National Youth Orchestra of Great Britain: Trustee.

A. Thomas McLellan

Mr. A. Thomas McLellan, Ph.D. serves as non-Executive Director of Indivior Plc. Over 35 years as a career researcher in the treatment and policy-making around substance use and abuse field, Published over 450 articles and chapters on addiction research, Treatment Research Institute (TRI): Co-founder, CEO and Chairman until September 1, 2016, White House Office of National Drug Control Policy (2009-2011): Deputy Director. Other current appointments: Serves on several editorial boards of scientific journals.

Daniel Tasse

Mr. Daniel Tasse serves as Senior Independent Director of Indivior Plc. Over 35 years of pharmaceutical and financial industry experience, Ikaria Holdings, Inc.: CEO and President (2008-2015), Chairman (2009-2015), Baxter International: General Manager of Pharmaceuticals and Technologies Business Unit, GlaxoSmithKline: various senior management positions including President and Regional Director for Australasia (2001-2004). Other current appointments: Alcresta Pharmaceuticals Inc.: Chairman and CEO, Bellerophon Therapeutics: Director, REGENXBIO Inc.: Director.

Yvonne Greenstreet

Ms. Yvonne Greenstreet serves as Non-Executive Independent Director of Indivior Plc. Over 20 years of pharmaceutical industry experience, Experienced in medicines development, medical affairs and business development, Pfizer Inc.: SVP Medicines Development (2010-2013), GlaxoSmithKline: various executive positions (1992-2010). Other current appointments: Alnylam: Chief Operating Officer, Pacira Pharmaceuticals, Inc.: Director , Moelis & Company: Independent Director.

Lorna Parker

Ms. Lorna Parker serves as Non-Executive Independent Director of Indivior Plc. Over 25 years of executive search, management assessment and board consulting experience, Conducts board effectiveness reviews for FTSE 100 companies, Spencer Stuart: Partner (1989-2008); led the private equity practice across Europe and the legal search practice globally, BC Partners: Senior Advisor (2008-2016), Future Academies: Director (2014-2017). Other current appointments: CVC Capital Partners: Senior Advisor, Manchester Square Partners: Senior Advisor, Royal Horticultural Society: Trustee, National Opera Studio: Trustee.

Daniel Phelan

Mr. Daniel J. Phelan serves as Non-Executive Independent Director of Indivior Plc. Over 30 years of pharmaceutical and executive management experience, Extensive experience dealing with executive remuneration and CEO succession planning, GlaxoSmithKline: advisor to three CEOs and various executive positions (1981-2012), Computer Sciences Corporation: Advisory Board Member (2013-2015), RiseSmart: Advisory Board Member(2012-2016), Rutgers University Board of Trustees: Member (2013-2017), Other current appointments: TE Connectivity Ltd: Board Director.

Christian Schade

Mr. Christian S. Schade serves as Non-Executive Independent Director of Indivior Plc. Over 20 years of pharmaceutical and financial industry experience, Novira Therapeutics, Inc.: CEO (2014-2015), Omthera Pharmaceuticals, Inc.: CFO, EVP (2011-2013), NRG Energy, Inc.: CFO, EVP (2010-2011), Medarex Inc.: CFO, SVP (2000-2009), Merrill Lynch & Co.: MD, Debt Capital Markets (1992-2000). Other current appointments: Aprea Therapeutics AB: President and Chief Executive Officer, Integra LifeSciences Holdings Corporation: Director, Sapience Therapeutics: Director.

Lizabeth Zlatkus

Ms. Lizabeth H. Zlatkus serves as Non-Executive Independent Director of Indivior Plc. The Hartford: various senior executive positions (1996-2011), Financial and risk expert, Audit, Risk Compensation and Nomination Committee experience, Legal & General: Non-Executive Director (2013-2016), Computer Sciences Corporation(2016-2017). Other current appointments: Boston Private Financial Holdings: Non-Executive Director, SE2: Board member, Connecticut Science Center: Board of Trustees, Executive Committee member, Penn State Business School: Board member and past Chair.